Onemednet collaborates with Palantir to Supercharge AI in health care

Onemednet Corp (Nasdak:ONMDShares Premark on Monday after the company revealed that it had chosen Palantir Technologies Inc. (Nasdak:Fungi) To Its health care is provided from artificial intelligence And data analysis in the real world.

OnemedNet takes advantage of Palantir analyzes to cancel the AI’s 868 billion dollars health care market by 2030 through safe, developmentable solutions.

Under a multi -year partnership, the artificial interfire platform, which is famous for integrating complex data collections and providing visions in actual time, with OneMednet.

Read the following: Old warriors collect awareness, Palantir, and Salesforce $ 21 million for payment.

The network provides access to more than 5 billion administrative claims and 131 million clinical tests through more than 1750 sites.

Cooperation extends to the main therapeutic fields, including tumors, heart disease and rare diseases.

Using the artificial intelligence platform in Palantir, OneMedNet will run IRWD near the AI’s already network.

The statute will provide life sciences, medical devices and research institutions access to unknown clinical data, organizational organization and advanced analyzes, and accelerate the development of medical innovations from the next generation.

Harun Green“AIP helps us in Palantir a revolution in our ability to provide high -quality data and is compatible with regulatory at a noticeable speed. This puts us in obtaining breakthroughs in clinical research and health care solutions driven by artificial intelligence.”

Price work: OnMD shares were traded by 46.60 % to $ 1.510 in the last two selection.

Read the following:

Photography by Michael V via Shutterstock

Unlocked: 5 new deals per week. Click now to get the best commercial ideas dailyIn addition to unlimited access to advanced tools and strategies to obtain a feature in the market.

Get the latest stock analysis from benzinga?

This article Onemednet collaborates with Palantir to Supercharge AI in health care Originally Benzinga.com

© 2025 benzinga.com. Benzinga does not provide investment advice. All rights reserved.